- Baseline characteristics of participants and their disease status.
| Variables | n | (%) |
|---|---|---|
| Age | ||
| Up to 20 years | 15 | (10.0) |
| 21-40 years | 76 | (50.7) |
| Above 40 years | 59 | (39.3) |
| Mean | 37.5 | |
| SD | ±13.5 | |
| Range | 54 | |
| Gender | ||
| Male | 95 | (63.3) |
| Female | 55 | (36.7) |
| Diabetes mellitus | ||
| Yes | 21 | (14.0) |
| No | 129 | (86.0) |
| Diagnosis | ||
| HL | 66 | (44.0) |
| NHL | 37 | (24.7) |
| MM | 40 | (26.7) |
| Pomes syndrome | 3 | (2.0) |
| APL | 3 | (2.0) |
| Germ cell tumor | 1 | (0.7) |
| Disease status pre-salvage for HL and NHL | ||
| Relapsed | 44 | (29.3) |
| Refractory | 56 | (37.3) |
| NA | 50 | (33.3) |
| Number of lines (salvage chemotherapy) | ||
| One line | 71 | (47.3) |
| Two lines | 22 | (14.7) |
| Three lines | 9 | (6.0) |
| Four lines | 1 | (0.7) |
| NA | 47 | (31.3) |
SD: standard deviation, HL: Hodgkin lymphoma, NHL: non-Hodgkin lymphoma, MM: multiple myeloma, APL: acute promyelocytic leukemia, NA: not applicable (multiple myeloma group)